Publikationen

Rosado-Ramos, R.; Poças, G. M.; Marques, D.; Foito, A.; Sevillano, D. M.; Lopes-da-Silva, M.; Gonçalves, L. G.; Menezes, R.; Ottens, M.; Stewart, D. et al.; de Opakua, A. I.; Zweckstetter, M.; Seabra, M. C.; Mendes, C. S.; Outeiro, T. F.; Domingos, P. M.; Santos, C. N.: Genipin prevents alpha-synuclein aggregation and toxicity by affecting endocytosis, metabolism and lipid storage. Nature Communications 14, 1918 (2023)

Xylaki, M.; Paiva, I.; Al-Azzani, M.; Gerhardt, E.; Jain, G.; Islam, M. R.; Vasili, E.; Wassouf, Z.; Schulze-Hentrich, J. M.; Fischer, A. et al.; Outeiro, T. F.: miR-101a-3p Impairs Synaptic Plasticity and Contributes to Synucleinopathy. Journal of Parkinson's Disease: JPD 13 (2), S. 179 - 196 (2023)

Shvachiy, L.; Geraldes, V.; Outeiro, T. F.: Uncovering the Molecular Link Between Lead Toxicity and Parkinson's Disease. Antioxidants & redox signaling, in press (2023)

Quesnel, A.; Coles, N.; Angione, C.; Dey, P.; Polvikoski, T. M.; Outeiro, T. F.; Islam, M.; Khundakar, A. A.; Filippou, P. S.: Glycosylation spectral signatures for glioma grade discrimination using Raman spectroscopy. BMC Cancer 23, 174 (2023)

Outeiro, T. F.; El-Agnaf, O. M.: The immune system in Parkinson's disease: From biology to diagnosis and therapeutic targets. Neurobiology of Disease 177, 105995 (2023)

Marsili, L.; Sharma, J.; Outeiro, T. F.; Colosimo, C.: Stem Cell Therapies in Movement Disorders: Lessons from Clinical Trials. Biomedicines 11 (2), 505 (2023)

Cullinane, P. W.; de Fernandez, E. P.; König, A.; Outeiro, T. F.; Jaunmuktane, Z.; Warner, T. T.: Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts. Movement Disorders 38 (2), S. 162 - 177 (2022)

Brás, I. C.; Khani, M. H.; Vasili, E.; Möbius, W.; Riedel, D.; Parfentev, I.; Gerhardt, E.; Fahlbusch, C.; Urlaub, H.; Zweckstetter, M. et al.; Gollisch, T.; Outeiro, T. F.: Molecular Mechanisms Mediating the Transfer of Disease-Associated Proteins and Effects on Neuronal Activity. Journal of Parkinson's Disease: JPD 12, S. 2397 - 2422 (2022)

Berkhoudt Lassen, L.; Schneider Thomsen, M.; Basso, E.; Füchtbauer, E.-M.; Füchtbauer, A.; Outeiro, T. F.; Jensen, P. H.; Moos, T.: Mutation of Tyrosine Sites in the Human Alpha-Synuclein Gene Induces Neurotoxicity in Transgenic Mice with Soluble Alpha-Synuclein Oligomer Formation. Cells 11 (22), 3673 (2022)

Brás, I. C.; Khani, M. H.; Riedel, D.; Parfentev, I.; Gerhardt, E.; van Riesen, C.; Urlaub, H.; Gollisch, T.; Outeiro, T. F.: Ectosomes and exosomes modulate neuronal spontaneous activity. Journal of Proteomics 269, 104721 (2022)

Magalhaes, R. S. S.; Boechat, F. C.; Brasil, A. A.; Neto, J. R. M.; Ribeiro, G. D.; Paranhos, L. H.; de Souza, N. N.; Vieira, T.; Outeiro, T. F.; Neves, B. C. et al.; Eleutherio, E. C. A.: Hexokinase 2: The preferential target of trehalose-6-phosphate over hexokinase 1. Journal of Cellular Biochemistry (2022)

Koss, D. J.; Erskine, D.; Porter, A.; Palmoski, P.; Menon, H.; Todd, O. G. J.; Leite, M.; Attems, J.; Outeiro, T. F.: Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies. Acta Neuropathologica Communications 10 (1), 98 (2022)

Domingues, R.; Sant'Anna, R.; Carvalho da Fonseca, A. C.; Robbs, B. K.; Foguel, D.; Outeiro, T. F.: Extracellular alpha-synuclein: Sensors, receptors, and responses. Neurobiology of Disease 168, 105696 (2022)

Oliveira, L. M. A.; Gasser, T.; Edwards, R.; Zweckstetter, M.; Melki, R.; Stefanis, L.; Lashuel, H. A.; Sulzer, D.; Vekrellis, K.; Halliday, G. M. et al.; Tomlinson, J. J.; Schlossmacher, M.; Jensen, P. H.; Schulze-Hentrich, J.; Riess, O.; Hirst, W.D.; El-Agnaf, O.; Mollenhauer, B.; Lansbury, P.; Outeiro, T. F.: Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease. NPJ Parkinsons Disease 7, 65 (2021)

Masaracchia, C.; Koenig, A.; Valiente-Gabioud, A. A.; Peralta, P.; Favretto, F.; Strohäker, T.; Lazaro, D. F.; Zweckstetter, M.; Fernandez, C. O.; Outeiro, T. F.: Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2020)

Vaz, R.; Chapela, D.; Coelho, J.; Lopez, L.; Ferreira, J.; Alfonso, N.; Sousa, S.; Outeiro, T. F.: Tapentadol Prevent Motor Impairments in a Mouse Model of Dyskinesia. Neuroscience 404, S. 58 - 71 (2020)

Brasil, A.D.; de Carvalho, M.D.C.; Gerhardt, E.; Queiroz, D.D.; Pereira, M.D.; Outeiro, T. F.; Eleutherio, E.C.A.: Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1. Proceedings of the National Academy of Sciences of the United States of America 116 (51), S. 25991 - 2600 (2019)

Szegö, É. M.; Dominguez-Meijide, A.; Gerhardt, E.; König, A.; Koss, D. J.; Li, W.; Pinho, R.; Fahlbusch, C.; Johnson, M.; Santos, P. et al.; Villar-Piqué, A.; Thom, T.; Rizzoli, S.; Schmitz, M.; Li, J.; Zerr, I.; Attems, J.; Jahn, O.; Outeiro, T. F.: Cytosolic trapping of a mitochondrial heat shock protein is an early pathological event in synucleinopathies. Cell Reports 28, S. 65 - 77 (2019)

Rossetti, G.; Kless, A.; Lai, L.; Outeiro, T. F.; Carloni, P.: Investigating targets for neuropharmacological intervention by molecular dynamics simulations. Biochemical Society Transactions 47, S. 909 - 918 (2019)

Wu, J.; Ardah, M.; Haikal, C.; Svanbergsson, A.; Diepenbroek, M.; Vaikath, N. N.; Li, W.; Wang, Z.-Y.; Outeiro, T. F.; El-Agnaf, O. M. et al.; Li, J.-Y.: Dihydromyricetin and salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy. Translational neurodegeneration 8, 18 (2019)